Literature DB >> 25217967

Prediction of Parkinson's disease subsequent to severe depression: a ten-year follow-up study.

Uwe Walter1, Robert Heilmann, Lara Kaulitz, Tino Just, Bernd Joachim Krause, Reiner Benecke, Jacqueline Höppner.   

Abstract

Major depressive disorder (MDD) has been associated with an increased risk of subsequent Parkinson's disease (PD) in case-control and cohort studies. However, depression alone is unlikely to be a useful marker of prodromal PD due to its low specificity. In this longitudinal observational study, we assessed whether the presence of other potential markers of prodromal PD predicts the subsequent development of PD in MDD patients. Of 57 patients with severe MDD but no diagnosis of PD who underwent a structured interview, olfactory and motor investigation and transcranial sonography at baseline, 46 (36 women; mean age 54.9 ± 11.7 years) could be followed for up to 11 (median, 10) years. Three patients (2 women; age 64, 65 and 70 years) developed definite PD after 1, 7, and 9 years, respectively. The combined finding of mild asymmetric motor slowing, idiopathic hyposmia, and substantia nigra hyperechogenicity predicted subsequent PD in all patients who could be followed for longer than 1 year. Out of the whole study cohort, only the subjects with subsequent PD presented with the triad of asymmetric motor slowing, idiopathic hyposmia, and substantia nigra hyperechogenicity in combination with at least two out of four reportable risk factors (family history of PD, current non-smoker, non-coffee drinker, constipation) at baseline investigation. Post-hoc analysis revealed that additional rating of eye and eye-lid motor abnormalities might further improve the prediction of PD in larger cohorts. Findings of this pilot-study suggest that MDD patients at risk of subsequent PD can be identified using an inexpensive non-invasive diagnostic battery.

Entities:  

Mesh:

Year:  2014        PMID: 25217967     DOI: 10.1007/s00702-014-1313-0

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  42 in total

1.  A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease.

Authors:  Miguel A Hernán; Bahi Takkouche; Francisco Caamaño-Isorna; Juan J Gestal-Otero
Journal:  Ann Neurol       Date:  2002-09       Impact factor: 10.422

Review 2.  Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease.

Authors:  Ronald B Postuma; Dag Aarsland; Paolo Barone; David J Burn; Christopher H Hawkes; Wolfgang Oertel; Tjalf Ziemssen
Journal:  Mov Disord       Date:  2012-04-15       Impact factor: 10.338

3.  Elevated putamen D(2) receptor binding potential in major depression with motor retardation: an [11C]raclopride positron emission tomography study.

Authors:  Jeffrey H Meyer; Heather E McNeely; Sandra Sagrati; Anahita Boovariwala; Krystle Martin; N Paul L G Verhoeff; Alan A Wilson; Sylvain Houle
Journal:  Am J Psychiatry       Date:  2006-09       Impact factor: 18.112

4.  Substantia nigra hyperechogenicity in depressive subjects relates to motor asymmetry and impaired word fluency.

Authors:  Jacqueline Hoeppner; Lara Prudente-Morrissey; Sabine Christiane Herpertz; Reiner Benecke; Uwe Walter
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-09-19       Impact factor: 5.270

5.  The motor agitation and retardation scale: a scale for the assessment of motor abnormalities in depressed patients.

Authors:  C Sobin; L Mayer; J Endicott
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1998       Impact factor: 2.198

6.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

7.  Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.

Authors:  Uwe Walter; Jacqueline Hoeppner; Lara Prudente-Morrissey; Sebastian Horowski; Sabine C Herpertz; Reiner Benecke
Journal:  Brain       Date:  2007-02-28       Impact factor: 13.501

8.  Clinical characteristics of neuroleptic-induced parkinsonism.

Authors:  S Hassin-Baer; P Sirota; A D Korczyn; T A Treves; B Epstein; H Shabtai; T Martin; Y Litvinjuk; N Giladi
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

9.  Catatonia in depression: prevalence, clinical correlates, and validation of a scale.

Authors:  S E Starkstein; G Petracca; A Tesón; E Chemerinski; M Merello; R Migliorelli; R Leiguarda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

10.  Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease.

Authors:  Daniela Berg; Stefanie Behnke; Klaus Seppi; Jana Godau; Stefanie Lerche; Philipp Mahlknecht; Inga Liepelt-Scarfone; Christoph Pausch; Niko Schneider; Alexandra Gaenslen; Kathrin Brockmann; Karin Srulijes; Heiko Huber; Isabel Wurster; Heike Stockner; Stefan Kiechl; Johann Willeit; Arno Gasperi; Klaus Fassbender; Thomas Gasser; Werner Poewe
Journal:  Mov Disord       Date:  2012-10-31       Impact factor: 10.338

View more
  5 in total

Review 1.  Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.

Authors:  Jennifer C Felger; Michael T Treadway
Journal:  Neuropsychopharmacology       Date:  2016-08-02       Impact factor: 7.853

Review 2.  [Helpful instrumental examinations in idiopathic Parkinson's disease].

Authors:  U Walter; H Zach; I Liepelt-Scarfone; W Maetzler
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

Review 3.  Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Implications for Treatment.

Authors:  Stéphane Prange; Hélène Klinger; Chloé Laurencin; Teodor Danaila; Stéphane Thobois
Journal:  Drugs Aging       Date:  2022-06-16       Impact factor: 4.271

4.  Tremor and clinical fluctuation are related to sleep disorders in Chinese patients with Parkinson's disease.

Authors:  Hongyan Zhou; Cunzhou Shen; Jie Chen; Hao Qian; Yifan Zheng; Yanmei Liu; Wenbiao Xian; Zhong Pei; Ling Chen
Journal:  Transl Neurodegener       Date:  2014-10-22       Impact factor: 8.014

Review 5.  Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned.

Authors:  Sebastian Heinzel; Benjamin Roeben; Yoav Ben-Shlomo; Stefanie Lerche; Guido Alves; Paolo Barone; Stefanie Behnke; Henk W Berendse; Bastiaan R Bloem; David Burn; Richard Dodel; Donald G Grosset; Michele Hu; Meike Kasten; Rejko Krüger; Marcello Moccia; Brit Mollenhauer; Wolfgang Oertel; Ulrike Suenkel; Uwe Walter; Karin Wirdefeldt; Inga Liepelt-Scarfone; Walter Maetzler; Daniela Berg
Journal:  Front Aging Neurosci       Date:  2016-06-22       Impact factor: 5.750

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.